跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
依立卢 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Fasudil Hydrochloride Injection
Approved
化学药品
Fasudil Hydrochloride Injection
ASAHI KASEI PHARMA CORPORATION
🇨🇳 National Medical Products Administration
Approval Date
May 6, 2020
Approval ID
7MazXbxy29e
Company
ASAHI KASEI PHARMA CORPORATION
Type
化学药品
Approval Details
Approval Id
7MazXbxy29e
Approval Number
H20150252
Generic Name
盐酸法舒地尔注射液
Generic Name En
Fasudil Hydrochloride Injection
Trade Name
依立卢
Brand Name
依立卢
Drug Type
化学药品
Dosage Form
注射剂
Strength
2ml:30mg
Reg Date
2020-05-06
Expired Date
2025-05-05
Company Name
ASAHI KASEI PHARMA CORPORATION
Company Address
1-1-2 Yurakucho, Chiyoda-ku, Tokyo Japan
Production Company Name
asahi kasei pharma corporation,nagoya pharmaceuticals plant
Production Company Address
61 Ikeda,Fukuta-cho,Miyoshi-shi,Aichi,Japan
Company Detail Path
/organization/asahi-kasei-pharma-corporation
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 6, 2020
Approval ID
7MazXbxy29e
Type
化学药品
Back to NMPA Approvals